Related Experiment Videos
Rosette-increasing factor released by PHA-stimulated mononuclear cells in vitro which augments active E and EA
Clinical and Experimental Immunology
|June 1, 1980
Summary
A newly discovered rosette-increasing factor (RIF) from T cells boosts active E and EA (IgG) receptor-forming cells (RFC), potentially enhancing cellular immunity. This factor
Area of Science:
- Immunology
- Cell Biology
Background:
- Phytohaemagglutinin (PHA) stimulates mononuclear (MN) cells.
- Active E and EA (IgG) receptor-forming cells (RFC) are linked to cell-mediated immunity.
Purpose of the Study:
- To identify and characterize a factor in PHA-stimulated mononuclear cells that influences RFC levels.
- To investigate the cellular origin and stability of this factor.
Main Methods:
- Stimulation of mononuclear cells with phytohaemagglutinin (PHA).
- Assay of cell-free supernatants for rosette-increasing factor (RIF) activity.
- Pretreatment of cells with cycloheximide, cytochalasin B, mitomycin C, and colchicine.
Main Results:
- A factor, termed rosette-increasing factor (RIF), was found in PHA-stimulated mononuclear cell supernatants.
- RIF significantly increased active E and EA (IgG) RFC, primarily T cells.
- RIF production was mainly by nylon wool-adherent T cells and independent of macrophages.
- RIF activity was abolished by cycloheximide and cytochalasin B but unaffected by mitomycin C and colchicine.
Conclusions:
- The rosette-increasing factor (RIF) is produced by T cells and enhances specific RFC populations.
- RIF stability and production kinetics suggest a role in cellular immune responses.
- Understanding RIF may offer insights into modulating cellular immunity.